SEC 13F Intelligence

Managers / Q4 2024 · view latest →

Silver Rock Financial LP

CIK 0001674784 · 12100 WILSHIRE BOULEVARD, SUITE 1000, LOS ANGELES, CA, 90025 · 424-371-8460

Reported Value
$583M
Q4 2024
Positions
28
Filings on Record
34
2019–present window
Filed
Feb 14, 2025
original filing

Summary

Silver Rock Financial LP reported $583M in U.S.-listed holdings across 28 positions for Q4 2024.

Its largest position, CMCSA, represents 2.9% of the portfolio.

Compared with Q3 2024, the fund opened 2 new positions and exited 13.

Portfolio Metrics

Turnover
+1.4%
vs prior filed quarter
Top-10 Concentration
+9.8%
share of reported value
Largest Position
+2.9%
Comcast
New / Exited
2 / 13
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $158MQ4 ’18Q1 ’19: $241MQ2 ’19: $411MQ3 ’19: $351MQ4 ’19: $266MQ4 ’19Q1 ’20: $71MQ2 ’20: $89MQ3 ’20: $175MQ4 ’20: $295MQ4 ’20Q1 ’21: $550MQ2 ’21: $616MQ3 ’21: $678MQ4 ’21: $585MQ4 ’21Q1 ’22: $525MQ2 ’22: $458MQ3 ’22: $456MQ4 ’22: $316MQ4 ’22Q1 ’23: $125MQ2 ’23: $52MQ3 ’23: $16MQ4 ’23: $17MQ4 ’23Q1 ’24: $20MQ2 ’24: $20MQ3 ’24: $408MQ4 ’24: $583MQ4 ’24Q1 ’25: $382MQ2 ’25: $399MQ3 ’25: $69MQ4 ’25: $56MQ4 ’25Q1 ’26: $50Mfilingsflow.com

Portfolio Composition

By security type
ETP: 90.2%Common Stock: 5.5%US DOMESTIC: 2.1%GLOBAL: 1.2%Other: 0.9%Equity WRT: 0.0%
  • ETP · 90.2% · $526M
  • Common Stock · 5.5% · $32M
  • US DOMESTIC · 2.1% · $12M
  • GLOBAL · 1.2% · $7M
  • Other · 0.9% · $5M
  • Equity WRT · 0.0% · $133,033

Quarter-over-Quarter Changes full breakdown →

vs Q3 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ECHOSTAR CORPNEW+6.88M6.88M+$7M$7M
BAIRD MED INVT HLDGS LTDNEW+48.9K48.9K+$10,023$10,023
CTEVMULTIPLAN CORPORATIONSOLD OUT126.1K0$963,404$0
EXCELFIN ACQUISITION CORPSOLD OUT48.9K0$7,295$0
ZAPATA COMPUTING HLDGS INCSOLD OUT103.2K0$3,686$0
NEW PROVIDENCE ACQSITN CORPSOLD OUT116.9K0$3,517$0
PERCEPTION CAPITAL CORP IVSOLD OUT69.9K0$3,516$0
GLOBAL TECHNOLGY ACQSTN CORPSOLD OUT63.6K0$3,229$0

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2024

27 positions
#IssuerClass% PortfolioValueShares
1CMCSACOMCAST CORP NEWhistory →CL A2.95%$17M457.5K
2DISH NETWORK CORPORATIONNOTE 12/12.07%$12M13.50M
3ECHOSTAR CORPNOTE 3.875%11/31.24%$7M6.88M
4CABOCABLE ONE INCCOM0.93%$5M15.0K
5VIVID SEATS INCCOM CL A0.90%$5M1.14M
6CYHCOMMUNITY HEALTH SYS INC NEWCOM0.77%$4M1.50M
7BRCCBRC INCCOM CL A0.47%$3M860.0K
8OPTUALTICE USA INCCL A0.41%$2M1.00M
9ARQIT QUANTUM INC*W EXP 09/03/2020.02%$112,41042.1K
10RGTIWRIGETTI COMPUTING INC*W EXP 03/02/2020.02%$101,66816.0K
11LIFEZONE METALS LIMITED*W EXP 07/05/2020.01%$34,87647.4K
12NRDYNERDY INCCL A COM0.00%$28,62217.7K
13BAIRD MED INVT HLDGS LTD*W EXP 10/01/2020.00%$10,02348.9K
14DAVEWDAVE INC*W EXP 01/05/2020.00%$6,56141.0K
15ROADZEN INC*W EXP 11/30/2020.00%$5,87739.2K
16BETRWBETTER HOME & FINANCE HOLDIN*W EXP 08/22/2020.00%$5,41045.1K
17ZEO ENERGY CORP*W EXP 03/13/2020.00%$5,10748.9K
18BNAIWBRAND ENGAGEMENT NETWORK INC*W EXP 03/14/2020.00%$4,44979.6K
19CARBON REVOLUTION LTD*W EXP 99/99/9990.00%$4,37566.9K
20COCHWENVOY MEDICAL INC*W EXP 09/29/2020.00%$3,82882.0K
21CHECHE GROUP INC*W EXP 10/01/2030.00%$3,76294.1K
22VAST RENEWABLES LIMITED*W EXP 07/01/2020.00%$2,96039.2K
23PAGAYA TECHNOLOGIES LTD*W EXP 99/99/9990.00%$2,80746.4K
24ALURWALLURION TECHNOLOGIES INC*W EXP 08/01/2030.00%$2,58986.3K
25VEEA INC*W EXP 09/13/2020.00%$2,29614.3K
26SONDER HOLDINGS INC*W EXP 01/18/2020.00%$1,024160.0K
27CEROWCERO THERAPEUTICS HLDGS INC*W EXP 02/13/2020.00%$10112.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$50M22May 12, 202613F-HRchanges · EDGAR ↗
Q4 2025$56M25Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$69M29Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$399M30Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$382M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$583M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$408M39Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$20M48Aug 14, 2024RESTATEMENTchanges · EDGAR ↗
Q1 2024$20M48May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$17M51Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$16M64Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$52M87Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$125M115May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$316M174Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$456M234Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$458M235Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$525M236May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$585M232Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$678M191Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$616M172Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$550M156May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$295M40Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$175M18Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$89M15Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$71M17May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$266M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$351M19Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$411M21Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$241M22May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$158M28Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.